All In MedTech

Device Trial Radar · NCT00565747

Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF

The Effect of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) During in Vitro Culture of Human Embryos on Subsequent Implantation Rates.

Last checked: Nov 19, 2026Latest source record: May 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,332 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,332

Actual

Start

Nov 2007

Primary completion

Nov 2010

Study completion Sep 2011

Sponsor

Lead sponsor
Origio A/SNot on our public-company list
Sponsor type
Industry
First posted
Nov 30, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 25 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to assess whether addition of 2 ng/ml GM-CSF into a specific culture medium will increase the chance of a pregnancy after in vitro fertilisation.

Conditions

  • Infertility

Interventions

  • Test cultureDevice

    A standard culture medium with added GM-CSF (ready-to-use)

  • Control cultureDevice

    The same standard culture medium, but without any additions (ready-to-use)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ongoing Implantation Rate Week 7Time frame: Approximately 5 weeks from oocyte pick-up (corresponding to 7 weeks from ovulation)

Locations

14 sites in 2 countries. Site status is shown where the registry gives one.

  • Maigaard Fertilitetsklinik

    Aarhus, Denmark

  • Ciconia Aarhus Privathospital, Fertilitetsklinikken

    Aarhus, Denmark

  • Brædstrup Sygehus; IVF-Klinikken

    Brædstrup, Denmark

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.